ILiAD Biotechnologies, LLC (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella Pertussis, today announced the peer-reviewed ...
SCOTTSDALE, AZ — Although Governor Katie Hobbs vetoed Senate Bill 1570, which would have opened the door for psychedelic treatment and testing facilities in Arizona, Scottsdale Research Center found a ...
The cancer center’s first test of the technology matched all of its manually identified clinical trials candidates and found additional appropriate patients beyond that. "The analysis was unambiguous: ...
MISSOULA, Mont. — A cancer-treatment compound (INI-4001), developed by the University of Montana in partnership with Inimmune Corp., is heading to Phase I human clinical trials. Previously, in animal ...
SHENZHEN, China, Sept. 17, 2025 /PRNewswire/ -- MagicRNA, a clinical-stage biotechnology company pioneering in vivo CAR T-cell therapies, today announced the publication of the world's first clinical ...
Please provide your email address to receive an email when new articles are posted on . Two different gene-edited pig kidneys have been successfully transplanted into living human patients under FDA’s ...
Breakthrough study paves the way for innovative, science-driven weight management solutions designed to activate optimal health at the cellular level* SALT LAKE CITY, Sept. 26, 2024 (GLOBE NEWSWIRE) - ...
A multisite research team has issued ethical and policy recommendations for first-in-human clinical trials involving the transplantation of pig kidneys into humans. The first trial has been approved ...
CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or the "Company"), a Singapore-based clinical stage biopharmaceutical company focused on harnessing ...
Artificial intelligence (AI) seems to be everywhere, but what is its future in clinical research? Clinical research inherently involves humans. However, it also involves numerous administrative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results